Associations of high sensitivity C-reactive protein levels in schizophrenia and comparison groups

Prediction of coronary heart disease using risk factor categories

Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581 · see citing works

C-reactive protein: a critical update

Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18921 · Cited by 4,576 · see citing works

C-reactive protein: a critical update

Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318921 · Cited by 3,436 · see citing works

Scale for the Assessment of Negative Symptoms (SANS)*

(1989) · The British Journal of Psychiatry · doi:10.1192/s0007125000291502 · Cited by 2,706 · see citing works

Clinical application of C-reactive protein for cardiovascular disease detection and prevention

Ridker, P. M. (2003) · Circulation · doi:10.1161/01.cir.0000053730.47739.3c · Cited by 2,513 · see citing works

Scale for Assessment of Positive Symptoms (SAPS) 1984

Andreasen, N. C. (1995) · Open Scholarship Institutional Repository (Washington University in St. Louis) · Cited by 2,423 · see citing works

Scale for the Assessment of Negative Symptoms

Andreasen, N. C. (1982) · PsycTESTS Dataset · doi:10.1037/t12696-000 · Cited by 1,878 · see citing works

C-reactive Protein

Black, S., Kushner, I., & Samols, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r400025200 · Cited by 1,844 · see citing works

TEST REVIEW: Dean C. Delis, Edith Kaplan & Joel H. Kramer, Delis Kaplan Executive Function System (D-KEFS), The Psychological Corporation, San Antonio, TX, 2001. $415.00 (complete kit)

Shunk, A. W., Davis, A. S., & Dean, R. S. (2006) · Applied Neuropsychology · doi:10.1207/s15324826an1304_9 · Cited by 1,528 · see citing works

Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly

Harris, T. B., Ferrucci, L., Tracy, R. P., Corti, M. C., Wacholder, S., Ettinger, W. H., Heimovitz, H., Cohen, H. J., & Wallace, R. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00066-2 · Cited by 1,488 · see citing works

Validation of the Cumulative Illness Rating Scale in a Geriatric Residential Population

Parmelee, P. A., THURAS, P. D., Katz, I. R., & Lawton, M. P. (1995) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1995.tb06377.x · Cited by 948 · see citing works

Antipsychotic Dose Equivalents and Dose-Years: A Standardized Method for Comparing Exposure to Different Drugs

Andreasen, N. C., Pressler, M., Nopoulos, P., Miller, D. D., & Ho, B. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.08.040 · Cited by 944 · see citing works

Socioeconomic status and health: the role of subjective social status

Demakakos, P., Nazroo, J., Breeze, E., & Marmot, M. (2008) · Social Science & Medicine · doi:10.1016/j.socscimed.2008.03.038 · Cited by 719 · see citing works

Socioeconomic Status And Health

(2002) · Health Affairs · doi:10.1377/hlthaff.21.2.47 · Cited by 667 · see citing works

C-Reactive Protein and the Prediction of Cardiovascular Events Among Those at Intermediate Risk

Ridker, P. M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.052 · Cited by 622 · see citing works

Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production

Zeyda, M., Farmer, D., Todoric, J., Aszmann, O. C., Speiser, M., Györi, G., Zlabinger, G. J., & Stulnig, T. M. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803632 · Cited by 553 · see citing works

Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects

Tracy, R. P., Psaty, B. M., Macy, E., Bovill, E. G., Cushman, M., Cornell, E. S., & Kuller, L. H. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.10.2167 · Cited by 539 · see citing works

C-Reactive Protein and Other Emerging Blood Biomarkers to Optimize Risk Stratification of Vulnerable Patients

Tsimikas, S., Willerson, J. T., & Ridker, P. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.10.066 · Cited by 335 · see citing works

Is schizophrenia a syndrome of accelerated aging?

Kirkpatrick, B., Messias, E., Harvey, P. D., Fernandez-Egea, E., & Bowie, C. R. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm140 · Cited by 335 · see citing works

Dietary inflammatory index and anthropometric measures of obesity in a population sample at high cardiovascular risk from the PREDIMED (PREvención con DIeta MEDiterránea) trial

Ruiz‐Canela, M., Zazpe, I., Shivappa, N., Hébert, J. R., Sánchez‐Tainta, A., Corella, D., Salas‐Salvadó, J., Fitó, M., Lamuela-Raventós, R. M., Rekondo, J., et al. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114514004401 · Cited by 280 · see citing works

C-Reactive Protein Levels in Schizophrenia

Miller, B. J., Culpepper, N. H., & Rapaport, M. H. (2013) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.micu.020813 · Cited by 263 · see citing works

Obesity and psychiatric disorders: Commonalities in dysregulated biological pathways and their implications for treatment

Lopresti, A. L., & Drummond, P. D. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.05.005 · Cited by 231 · see citing works

C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophrenia

Dickerson, F., Stallings, C. R., Origoni, A. E., Boronow, J. J., & Yolken, R. H. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.03.022 · Cited by 205 · see citing works

Cardiovascular Risk Prediction Models for People With Severe Mental Illness: Results From the Prediction and Management of Cardiovascular Risk in People With Severe Mental Illnesses (PRIMROSE) Research Program

Osborn, D. P. J., Hardoon, S., Omar, R. Z., Holt, R. I. G., King, M., Larsen, J., Marston, L., Morris, R. W., Nazareth, I., Walters, K., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.2133 · Cited by 200 · see citing works

Age and neuropsychologic function in schizophrenia: a decline in executive abilities beyond that observed in healthy volunteers

Fucetola, R. P., Seidman, L. J., Kremen, W. S., Faraone, S. V., Goldstein, J. M., & Tsuang, M. T. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00240-7 · Cited by 167 · see citing works

Immune dysregulation and self‐reactivity in schizophrenia: Do some cases of schizophrenia have an autoimmune basis?

Jones, A. L., Mowry, B. J., Pender, M. P., & Greer, J. M. (2005) · Immunology and Cell Biology · doi:10.1111/j.1440-1711.2005.01305.x · Cited by 155 · see citing works

Cognition in schizophrenia : impairments, importance, and treatment strategies

Sharma, T., & Harvey, P. D. (2000) · Oxford University Press eBooks · Cited by 146 · see citing works

Revisiting the factor structure for positive and negative symptoms: evidence from a large heterogeneous group of psychiatric patients

Toomey, R., Kremen, W. S., Simpson, J. C., SAMSON, J. A., Seidman, L. J., Lyons, M. J., Faraone, S. V., & Tsuang, M. T. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.3.371 · Cited by 135 · see citing works

Inflammation and schizophrenia

Fan, X., GOFF, D. C., & Henderson, D. C. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.7.789 · Cited by 117 · see citing works

A Controlled Prospective Study of Toxoplasma gondii Infection in Individuals With Schizophrenia: Beyond Seroprevalence

Hinze‐Selch, D., Däubener, W., Eggert, L., Erdag, S., Stoltenberg, R. L., & Wilms, S. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm010 · Cited by 117 · see citing works

Wellness within illness: Happiness in schizophrenia

Palmer, B. W., Martin, A. S., Depp, C. A., Glorioso, D. K., & Jeste, D. V. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.07.027 · Cited by 113 · see citing works

Cognitive impairment of executive function as a core symptom of schizophrenia

Wobrock, T., Ecker, U. K. H., Scherk, H., Schneider-Axmann, T., Falkai, P., & Gruber, O. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970701849986 · Cited by 102 · see citing works

Inflammatory markers in antipsychotic-naïve patients with nonaffective psychosis and deficit vs. nondeficit features

García‐Rizo, C., Fernández-Egea, E., Oliveira, C., Justicia, A., Bernardo, M., & Kirkpatrick, B. W. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2011.08.014 · Cited by 90 · see citing works

C-reactive protein serum level in drug-free male Egyptian patients with schizophrenia

Fawzi, M. H., Fawzi, M. M., Fawzi, M. M., & Said, N. S. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2011.05.010 · Cited by 89 · see citing works

Inflammation and psychotropic drugs: the relationship between C-reactive protein and antipsychotic drug levels

Hefner, G., Shams, M. E. E., Unterecker, S., Falter, T., & Hiemke, C. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3976-0 · Cited by 83 · see citing works

Mortality among People with Severe Mental Disorders Who Reach Old Age: A Longitudinal Study of a Community-Representative Sample of 37892 Men

Almeida, O. P., Hankey, G. J., Yeap, B. B., Golledge, J., Norman, P. E., & Flicker, L. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111882 · Cited by 82 · see citing works

Additive effects of elevated C-reactive protein and exposure to Herpes Simplex Virus type 1 on cognitive impairment in individuals with schizophrenia

Dickerson, F., Stallings, C. R., Origoni, A. E., Vaughan, C., Khushalani, S., & Yolken, R. H. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.10.003 · Cited by 81 · see citing works

Association of blood levels of C-reactive protein with clinical phenotypes in Arab schizophrenic patients

Akanji, A. O., OHAERI, J. U., Al-Shammri, S., & Fatania, H. R. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2008.06.010 · Cited by 68 · see citing works

Increased Framingham 10-year risk of coronary heart disease in middle-aged and older patients with psychotic symptoms

Jin, H., Folsom, D. P., Sasaki, A., Mudaliar, S. R. D., Henry, R. R., Torres, M., Golshan, S., Glorioso, D., & Jeste, D. V. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.10.029 · Cited by 55 · see citing works

Mortality in schizophrenia: clinical and serological predictors

Dickerson, F., Stallings, C., Origoni, A., Schroeder, J., Khushalani, S., & Yolken, R. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt113 · Cited by 50 · see citing works

Body Mass Index Identified as an Independent Predictor of Psychiatric Readmission

Manu, P., Khan, S., Radhakrishnan, R., Russ, M. J., Kane, J. M., & Correll, C. U. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08795 · Cited by 45 · see citing works

Executive dysfunction in schizophrenia

Leicester, S. (2002) · Research Online (University of Wollongong) · Cited by 44 · see citing works

Executive Dysfunction in Schizophrenia

Palmer, B. W., & Heaton, R. K. (2000) · doi:10.1093/oso/9780192629937.003.0003 · Cited by 39 · see citing works

The effects of cigarette smoking on C-reactive protein concentrations in men and women and its modification by exogenous oral hormones in women

Dietrich, T., García, R. I., de Pablo, P., Schulze, P. C., & Hoffmann, K. (2007) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e328270b913 · Cited by 36 · see citing works

Increased Framingham 10-year CVD risk in Chinese patients with schizophrenia

Tay, Y. H., Nurjono, M., & Lee, J. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.03.023 · Cited by 34 · see citing works

C-reactive protein as a marker of cardiovascular disease in patients with a schizophrenia spectrum disorder treated in routine medical practice

Sicras‐Mainar, A., Rejas, J., Navarro‐Artieda, R., & Blanca-Tamayo, M. (2011) · European Psychiatry · doi:10.1016/j.eurpsy.2011.07.003 · Cited by 34 · see citing works

Sex difference and the role of leptin in the association between high-sensitivity C-reactive protein and adiposity in two different populations

Rossi, I. A., Bochud, M., Bovet, P., Paccaud, F. M., Waeber, G., Vollenweider, P., & Taffé, P. (2012) · European Journal of Epidemiology · doi:10.1007/s10654-012-9671-0 · Cited by 33 · see citing works

Total and differential white blood cell counts, high-sensitivity C-reactive protein, and cardiovascular risk in non-affective psychoses

Miller, B. J., Kandhal, P. K., Rapaport, M. H., Mellor, A. L., & Buckley, P. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.12.005 · Cited by 31 · see citing works

Effect of Ramadan fasting on anthropometric, metabolic, inflammatory and psychopathology status of Egyptian male patients with schizophrenia

Fawzi, M. H., Fawzi, M. M., Said, N. S., Fawzi, M. M., Fouad, A. A., & Abdel-Moety, H. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.11.057 · Cited by 25 · see citing works

The prevalence of cardiometabolic risk factors and the ten-year risk of fatal cardiovascular events in patients with schizophrenia and related psychotic disorders.

Protopopová, D., Masopust, J., Malý, R., Vališ, M., & Bažant, J. (2012) · PubMed · Cited by 23 · see citing works

Obesity-related correlation between C-reactive protein and the calculated 10-y Framingham Coronary Heart Disease Risk Score

Rogowski, O., Shapira, I., Toker, S., Melamed, S., Shirom, A., Berliner, S. A., & Zeltser, D. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0802939 · Cited by 22 · see citing works

Coronary disease risk prediction algorithm warranting incorporation of C-reactive protein in Turkish adults, manifesting sex difference

Onat, A., Can, G., Hergenç, G., Uğur, M., & Yüksel, H. (2011) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.10.010 · Cited by 17 · see citing works

Cardiovascular risk factor associations in adults with psychosis and adults in a national comparator sample

Foley, D. L., Mackinnon, A. J., Morgan, V. A., Watts, G. F., Shaw, J. E., Magliano, D. J., Castle, D. J., McGrath, J. J., Waterreus, A. J., & Galletly, C. A. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867414565476 · Cited by 12 · see citing works

Relationship Between Metabolic Syndrome and Clinical Features, and Its Personal-Social Performance in Patients with Schizophrenia

Saatçioğlu, Ö., Kalkan, M., Fıstikçı, N., Erek, Ş., & Kılıc, K. C. (2015) · Psychiatric Quarterly · doi:10.1007/s11126-015-9384-0 · Cited by 10 · see citing works

Significant sex difference in the association between C‐reactive protein concentration and anthropometry among 13‐ to 19‐year olds, but not 6‐ to 12‐year olds in Nepal

Konishi, S., Parajuli, R. P., Takane, E., Maharjan, M., Tachibana, K., Jiang, H., Pahari, K., Inoue, Y., Umezaki, M., & Watanabe, C. (2014) · American Journal of Physical Anthropology · doi:10.1002/ajpa.22470 · Cited by 9 · see citing works

High prevalence and adverse health effects of loneliness in community-dwelling adults across the lifespan: role of wisdom as a protective factor

Lee, E. E., Depp, C., Palmer, B. W., Glorioso, D., Daly, R., Liu, J., Tu, X. M., Kim, H.-C., Tarr, P., Yamada, Y., et al. (2019) · International Psychogeriatrics · doi:10.1017/s1041610218002120 · Cited by 286 · see citing works

Socioeconomic status and inflammation: a meta-analysis

Muscatell, K. A., Brosso, S. N., & Humphreys, K. L. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0259-2 · Cited by 276 · see citing works

Differences in gut microbiome composition between persons with chronic schizophrenia and healthy comparison subjects

Nguyen, T. T., Kosciolek, T., Maldonado, Y., Daly, R. E., Martin, A. S., McDonald, D., Knight, R., & Jeste, D. V. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2018.09.014 · Cited by 260 · see citing works

Cytokines and C-reactive protein alterations with respect to cognitive impairment in schizophrenia and bipolar disorder: A systematic review

Misiak, B., Stańczykiewicz, B., Kotowicz, K., RYBAKOWSKI, J. K., Samochowiec, J., & Frydecka, D. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.04.015 · Cited by 198 · see citing works

C-Reactive protein as a biomarker for major depressive disorder?

Orsolini, L., Pompili, S., Tempia Valenta, S., Salvi, V., & Volpe, U. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031616 · Cited by 171 · see citing works

Peripheral inflammatory and neurotrophic biomarkers of cognitive impairment in schizophrenia: a meta-analysis

Bora, E. (2019) · Psychological Medicine · doi:10.1017/s0033291719001685 · Cited by 150 · see citing works

Neuroinflammation in schizophrenia: the role of nuclear factor kappa B

Murphy, C. E., Walker, A. K., & Weickert, C. S. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01607-0 · Cited by 128 · see citing works

The relationship between inflammatory biomarkers and cognitive dysfunction in patients with schizophrenia: A systematic review and meta-analysis

Patlola, S. R., Donohoe, G. J., & McKernan, D. P. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110668 · Cited by 122 · see citing works

Inflammation in Schizophrenia: Cytokine Levels and Their Relationships to Demographic and Clinical Variables

Lee, E., Hong, S., Martin, A. S., Eyler, L. T., & Jeste, D. V. (2016) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2016.09.009 · Cited by 113 · see citing works

Protein-C Reactive as Biomarker Predictor of Schizophrenia Phases of Illness? A Systematic Review

Orsolini, L., Sarchione, F., Vellante, F., Fornaro, M., Matarazzo, I., Martinotti, G., Valchera, A., Nicola, M. D., Carano, A., Giannantonio, M. D., et al. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180119144538 · Cited by 102 · see citing works

Chronic Peripheral Inflammation is Associated With Cognitive Impairment in Schizophrenia: Results From the Multicentric FACE-SZ Dataset

Bulzacka, E., Boyer, L., Schürhoff, F., Godin, O., Berna, F. S., Brunel, L., Andrianarisoa, M., Aouizerate, B., Capdevielle, D., Chéreau, I., et al. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw029 · Cited by 99 · see citing works

Modified Mediterranean Diet for Enrichment of Short Chain Fatty Acids: Potential Adjunctive Therapeutic to Target Immune and Metabolic Dysfunction in Schizophrenia?

Joseph, J., Depp, C. A., Shih, P.-A. B., Cadenhead, K. S., & Schmid‐Schönbein, G. W. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00155 · Cited by 95 · see citing works

Multi-omics of human plasma reveals molecular features of dysregulated inflammation and accelerated aging in schizophrenia

Campeau, A., Mills, R. H., Stevens, T. W., Rossitto, L.-A. M., Meehan, M. J., Dorrestein, P. C., Daly, R., Nguyen, T. T., Gonzalez, D. J., Jeste, D. V., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01339-z · Cited by 94 · see citing works

C-Reactive Protein as a Peripheral Biomarker in Schizophrenia. An Updated Systematic Review

Fond, G. B., Lançon, C., Auquier, P., & Boyer, L. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00392 · Cited by 95 · see citing works

Greater extracellular free-water in first-episode psychosis predicts better neurocognitive functioning

Lyall, A. E., Pasternak, O., Robinson, D. G., Newell, D., Trampush, J. W., Gallego, J. A., D, M. F. M., Malhotra, A. K., Karlsgodt, K. H., Kubicki, M. R., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.43 · Cited by 91 · see citing works

Abnormalities in chemokine levels in schizophrenia and their clinical correlates

Hong, S., Lee, E., Martin, A. S., Soontornniyomkij, B., Soontornniyomkij, V., Achim, C. L., Reuter, C., Irwin, M. R., Eyler, L. T., & Jeste, D. V. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.09.019 · Cited by 91 · see citing works

The relationship between immune and cognitive dysfunction in mood and psychotic disorder: a systematic review and a meta-analysis

Morrens, M., Overloop, C., Coppens, V., Loots, E., Noortgate, M. V. D., Vandenameele, S., Leboyer, M., & Picker, L. D. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01582-y · Cited by 70 · see citing works

Abnormal levels of vascular endothelial biomarkers in schizophrenia

Nguyen, T. T., Dev, S. I., Chen, G., Liou, S. C., Martin, A. S., Irwin, M. R., Carroll, J., Tu, X. M., Jeste, D. V., & Eyler, L. T. (2017) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-017-0842-6 · Cited by 66 · see citing works

Childhood Adversity and Schizophrenia

Lee, E., Martin, A. S., Tu, X. M., Palmer, B. W., & Jeste, D. V. (2018) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.17m11776 · Cited by 64 · see citing works

Sleep disturbances and inflammatory biomarkers in schizophrenia: focus on sex differences

Lee, E. E., Ancoli-Israel, S., Eyler, L. T., Tu, X. M., Palmer, B. W., Irwin, M. R., & Jeste, D. V. (2019) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2018.09.017 · Cited by 58 · see citing works

Metabolic-inflammatory status as predictor of clinical outcome at 1-year follow-up in patients with first episode psychosis

Nettis, M. A., Pergola, G., Kolliakou, A., O’Connor, J. A., Bonaccorso, S., David, A. S., Gaughran, F., Forti, M. D., Murray, R. M., Marques, T. R., et al. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.09.005 · Cited by 56 · see citing works

Regulation of inflammatory pathways in schizophrenia: A comparative study with bipolar disorder and healthy controls

García-Álvarez, L., Caso, J. R., García‐Portilla, M. P., de la Fuente-Tomás, L., González-Blanco, L., Sáiz, P. A., Leza, J. C., & Bobes, J. (2017) · European Psychiatry · doi:10.1016/j.eurpsy.2017.09.007 · Cited by 56 · see citing works

Integrity of the arcuate fasciculus in patients with schizophrenia with auditory verbal hallucinations: A DTI-tractography study

Psomiades, M., Fonteneau, C., Mondino, M., Luck, D., Haesebaert, F., Suaud‐Chagny, M., & Brunelin, J. (2016) · NeuroImage Clinical · doi:10.1016/j.nicl.2016.04.013 · Cited by 52 · see citing works

iTRAQ technology-based identification of human peripheral serum proteins associated with depression

Wang, Q., Su, X., Jiang, X., Dong, X., Fan, Y., Zhang, J., Yu, C., Gao, W., Shi, S., Jiang, J., et al. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.05.055 · Cited by 49 · see citing works

Cognitive impairment in psychiatric diseases: Biomarkers of diagnosis, treatment, and prevention

Wang, Y., Meng, W., Liu, Z., An, Q., & Hu, X. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.1046692 · Cited by 49 · see citing works

Leukocyte telomere length: Effects of schizophrenia, age, and gender

Wolkowitz, O. M., Jeste, D. V., Martin, A. S., Lin, J., Daly, R. E., Reuter, C., & KRAEMER, H. C. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.10.015 · Cited by 47 · see citing works

Metabolic dysregulation in first-episode schizophrenia patients with respect to genetic variation in one-carbon metabolism

Misiak, B., Łaczmański, Ł., Słoka, N. K., Szmida, E., Piotrowski, P., Loska, O., Ślężak, R., Kiejna, A., & Frydecka, D. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.01.077 · Cited by 46 · see citing works

Plasma Levels of Neuron- and Astrocyte-Derived Exosomal Amyloid Beta1-42, Amyloid Beta1-40, and Phosphorylated Tau Levels in Schizophrenia Patients and Non-psychiatric Comparison Subjects: Relationships With Cognitive Functioning and Psychopathology

Lee, E., Winston-Gray, C., Barlow, J. W., Rissman, R. A., & Jeste, D. V. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.532624 · Cited by 39 · see citing works

Increased ratio of high sensitivity C-reactive protein to interleukin-10 as a potential peripheral biomarker of schizophrenia and aggression

Zhang, Q., Hong, W., Li, H., Peng, F., Wang, F., Li, N., Xiang, H., Zhang, Z., Su, Y., Huang, Y., et al. (2017) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2017.02.001 · Cited by 39 · see citing works

Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort

Fond, G. B., Resseguier, N., Schürhoff, F., Godin, O., Andrianarisoa, M., Brunel, L., Bulzacka, E., Aouizerate, B., Berna, F. S., Capdevielle, D., et al. (2017) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-017-0847-1 · Cited by 38 · see citing works

The expression of toll-like receptors in peripheral blood mononuclear cells is altered in schizophrenia

Kozłowska, E., Agier, J., Wysokiński, A., Łucka, A., Sobierajska, K., & Brzezińska‐Błaszczyk, E. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.12.138 · Cited by 36 · see citing works

Adiposity-independent hypoadiponectinemia as a potential marker of insulin resistance and inflammation in schizophrenia patients treated with second generation antipsychotics

Sapra, M., Lawson, D. M., Iranmanesh, A., & Varma, A. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.04.051 · Cited by 33 · see citing works

Relation of inflammatory markers with symptoms of psychotic disorders: a large cohort study

Liemburg, E. J., Nolte, I. M., Klein, H. C., & Knegtering, H. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.04.006 · Cited by 32 · see citing works

Decreased Serum Oxytocin and Increased Homocysteine in First-Episode Schizophrenia Patients

Liu, Y., Tao, H., Yang, X., Huang, K., Zhang, X., & Li, C. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00217 · Cited by 32 · see citing works

Elevated plasma F2-isoprostane levels in schizophrenia

Lee, E., Eyler, L. T., Wolkowitz, O. M., Martin, A. S., Reuter, C., KRAEMER, H. C., & Jeste, D. V. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.06.011 · Cited by 31 · see citing works

Elevation of plasma neutrophil gelatinase-associated lipocalin (NGAL) levels in schizophrenia patients

Wei, L., Du, Y., Wu, W., Fu, X., & Xia, Q. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.10.002 · Cited by 31 · see citing works

The Association Between Neuropsychological Function with Serum Vitamins A, D, and E and hs-CRP Concentrations

Bahrami, A., Bahrami‐Taghanaki, H., Khorasanchi, Z., Tayefi, M., Ferns, G. A., Sadeghnia, H. R., & Ghayour‐Mobarhan, M. (2019) · Journal of Molecular Neuroscience · doi:10.1007/s12031-019-01288-x · Cited by 21 · see citing works

Improvement of adjunctive berberine treatment on negative symptoms in patients with schizophrenia

Li, M., Qiu, Y., Zhang, J., Zhang, Y., Liu, Y., Zhao, Y., Jia, Q., Fan, X., & Li, J. (2022) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-021-01359-4 · Cited by 21 · see citing works

Serum Levels of High Sensitivity C-reactive Protein in Drug-naïve First-episode Psychosis and Acute Exacerbation of Schizophrenia

Bolu, A., Aydın, M. S., Akgün, A., Coşkun, A., Garip, B., Öznur, T., Çelik, C., & Uzun, Ö. (2019) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2019.17.2.244 · Cited by 21 · see citing works

Clinical Correlates of Insulin Resistance in Chronic Schizophrenia: Relationship to Negative Symptoms

Soontornniyomkij, V., Lee, E. E., Jin, H., Martin, A., Daly, R., Liu, J., Tu, X., Eyler, L., & Jeste, D. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00251 · Cited by 19 · see citing works

Serum C-Reactive Protein in Patients with Deficit Schizophrenia and the Relationship with Cognitive Function

Pan, L.-H., Qian, M. D., Qu, W., Tang, Q., & Yan, Y. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s284149 · Cited by 18 · see citing works

Associations between inflammatory marker profiles and neurocognitive functioning in people with schizophrenia and non-psychiatric comparison subjects

Adamowicz, D. H., Shilling, P. D., Palmer, B. W., Nguyen, T. T., Wang, E., Liu, C., Tu, X. M., Jeste, D. V., Irwin, M. R., & Lee, E. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.02.029 · Cited by 17 · see citing works

Comparison of Schizophrenia Outpatients in Residential Care Facilities with Those Living with Someone: Study of Mental and Physical Health, Cognitive Functioning, and Biomarkers of Aging

Lee, E. E., Martin, A., Kaufmann, C. N., Liu, J., Kangas, J. L., Daly, R., Tu, X., Depp, C., & Jeste, D. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.02.067 · Cited by 18 · see citing works

C-Reactive Protein (CRP): A Potent Inflammation Biomarker in Psychiatric Disorders

Orsolini, L., Pompili, S., & Volpe, U. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_7 · Cited by 17 · see citing works

High serum soluble tumor necrosis factor receptor 1 predicts poor treatment response in acute-stage schizophrenia

Nishimon, S., Ohnuma, T., Takebayashi, Y., Katsuta, N., Takeda, M., Nakamura, T., Sannohe, T., Higashiyama, R. I., Kimoto, A., Shibata, N., et al. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.03.006 · Cited by 16 · see citing works

Common and disorder-specific upregulation of the inflammatory markers TRAIL and CCL20 in depression and schizophrenia

Klaus, F., Guetter, K., Schlegel, R., Spiller, T. R., Seifritz, E., Cathomas, F., & Kaiser, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-98769-0 · Cited by 17 · see citing works

The association of SOD and HsCRP with the efficacy of sulforaphane in schizophrenia patients with residual negative symptoms

Zeng, J., Zhang, W., Lu, X., Zhou, H., Huang, J. H., Xu, Z., Liao, H., Liang, J., Liang, M., Ye, C., et al. (2023) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-023-01679-7 · Cited by 15 · see citing works

Plasma GDF15 level is elevated in psychosis and inversely correlated with severity

Kumar, P., Millischer, V., Villaescusa, J. C., Nilsson, I. A. K., Östenson, C., Schalling, M., Ösby, U., & Lavebratt, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-07503-2 · Cited by 16 · see citing works

Correlations between Body Mass Index, Plasma High-Sensitivity C-Reactive Protein and Lipids in Patients with Schizophrenia

Boozalis, T., Devaraj, S., & Okusaga, O. O. (2018) · Psychiatric Quarterly · doi:10.1007/s11126-018-9606-3 · Cited by 15 · see citing works

Metabolic disturbances, hemoglobin A1c, and social cognition impairment in Schizophrenia spectrum disorders

Tang, S. X., Oliver, L. D., Hänsel, K., DeRosse, P., John, M., Khairullah, A., Gold, J. M., Buchanan, R. W., Voineskos, A. N., & Malhotra, A. K. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02002-z · Cited by 15 · see citing works

Serum high-sensitivity C-reactive protein: A delicate sentinel elevated in drug-free acutely agitated patients with schizophrenia

Pan, S., Tan, Y., Yao, S., Zhao, X., & Xiong, J. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.09.033 · Cited by 15 · see citing works

Association between C-reactive protein levels and antipsychotic treatment during 12 months follow-up period after acute psychosis

Fathian, F., Gjestad, R., Kroken, R. A., Løberg, E., Reitan, S. K., Fleichhacker, W. W., Rettenbacher, M. A., Larsen, T. K., Joa, I., Stabell, L. A., et al. (2022) · Schizophrenia Research · doi:10.1016/j.schres.2022.01.049 · Cited by 15 · see citing works

Serum level of high sensitive C-reactive protein and IL − 6 markers in patients with treatment-resistant schizophrenia in Ethiopia: a comparative study

Challa, F., Seifu, D., Sileshi, M., Getahun, T., Geto, Z., Kassa, D., Alemayehu, M., Mesfin, M., Fekadu, A., & Woldeamanuel, Y. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03443-4 · Cited by 14 · see citing works

Eveningness chronotype and depressive affective temperament associated with higher high-sensitivity C-reactive protein in unipolar and bipolar depression

Orsolini, L., Ricci, L., Pompili, S., Cicolini, A., & Volpe, U. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.04.004 · Cited by 13 · see citing works

Elevated C-reactive protein as a predictor of a random one-year clinical course in the first ten years of schizophrenia

González-Blanco, L., García‐Portilla, M. P., García-Álvarez, L., de la Fuente-Tomás, L., García, C. I., Sáiz, P. A., & Bobes, J. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.08.042 · Cited by 12 · see citing works

Galectin-1 and Galectin-3 Levels in Patients with Schizophrenia and their Unaffected Siblings

Yüksel, R. N., Göverti, D., Kahve, A. C., Çakmak, I. B., Yücel, Ç., & Göka, E. (2020) · Psychiatric Quarterly · doi:10.1007/s11126-020-09731-8 · Cited by 12 · see citing works

Comparison of thin-strut cobalt-chromium stents and stainless steel stents in a porcine model of neointimal hyperplasia.

Milewski, K. P., Żurakowski, A., Pająk, J., Pajak-Zielinska, E., Liszka, Ł., Buszman, P. P., Bis, J., Dębiński, M., & Buszman, P. E. (2010) · PubMed · Cited by 11 · see citing works

Cognitive impairment and C-reactive protein in clinically stable schizophrenia outpatients: a focus on sex differences

Santo, F. D., González-Blanco, L., García-Álvarez, L., de la Fuente-Tomás, L., Velasco, Á., Alvarez-Vázquez, C., Martínez-Cao, C., Sáiz, P. A., García‐Portilla, M. P., & Bobes, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-73043-x · Cited by 11 · see citing works

Cannabis Cessation, Inflammatory Markers and Schizophrenia

Roméo, B., Lestra, V., Martelli, C., Benyamina, A., & Hamdani, N. (2022) · Journal of Dual Diagnosis · doi:10.1080/15504263.2021.2013697 · Cited by 11 · see citing works

Interplay of inflammatory biomarkers in heart disease patients with depressive symptoms: An update

Varghese, T. P., Chand, S., Varghese, N. M., Singh, R., & Yadav, S. K. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.102352 · Cited by 12 · see citing works

C-reactive protein is associated with severity of thought and language dysfunction in patients with schizophrenia

Chang, C.-H., Lane, H., Liu, C., Cheng, P.-C., Chen, S.-J., & Lin, C. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s223278 · Cited by 11 · see citing works

Avoidance of accelerated aging in schizophrenia?: Clinical and biological characterization of an exceptionally high functioning individual

Palmer, B. W., Moore, R. C., Eyler, L. T., Pinto, L. L., Saks, E. R., & Jeste, D. V. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.07.052 · Cited by 10 · see citing works

What can we learn about brain donors? Use of clinical information in human postmortem brain research

Sullivan, K., Pantazopoulos, H., Liebson, E. S., Woo, T., Baldessarini, R. J., Hedreen, J. C., & Berretta, S. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63639-3.00014-1 · Cited by 8 · see citing works

Serum high-sensitivity C-reactive protein levels are positively associated with cognitive impairments in patients with first-episode schizophrenia

Zhu, J., Hu, W., Zhou, Y., Qiao, J., Chang, X., & Tong, Z. (2019) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2019.152118 · Cited by 10 · see citing works

Linking Metabolic Disorders and Immune System Phenomena in Schizophrenia: The Role of Adipose Tissue and Inflammation

Oracz, A. J., Zwierz, M., Naumowicz, M., Modzelewski, S., Suprunowicz, M., & Waszkiewicz, N. (2025) · Biomedicines · doi:10.3390/biomedicines13092308 · Cited by 9 · see citing works

A scoping review of protein biomarkers for schizophrenia: State of progress, underlying biology, and methodological considerations

Berdeville, C. H. D. S. F., Silva-Amaral, D., Dalgalarrondo, P., Banzato, C. E. M., & Martins‐de‐Souza, D. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105949 · Cited by 9 · see citing works

The longitudinal relations between physical activity, inflammation, and depression in the Health and Retirement Study

Levihn‐Coon, A., Smits, J. A. J., & Beevers, C. G. (2025) · PLOS mental health. · doi:10.1371/journal.pmen.0000211 · Cited by 8 · see citing works

Executive functioning trajectories and their prospective association with inflammatory biomarkers in schizophrenia and non-psychiatric comparison participants

Adamowicz, D. H., Wu, T., Daly, R., Irwin, M. R., Jeste, D. V., Tu, X. M., Eyler, L. T., & Lee, E. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110866 · Cited by 7 · see citing works

Quality of Life and C-Reactive Protein in Patients with Schizophrenia: A Cross-Sectional Study

Kachouchi, A., Laatabi, A., Saadia, K., Imane, A., & Fatiha, M. (2024) · ALPHA PSYCHIATRY · doi:10.5152/alphapsychiatry.2024.231437 · Cited by 7 · see citing works

Joint evaluation of serum C-Reactive Protein levels and polygenic risk scores as risk factors for schizophrenia

Nimgaonkar, V. L., Dickerson, F., Pouget, J. G., Chowdari, K. V., O’Dushlaine, C. T., Wood, J. A., Klei, L., Devlin, B., & Yolken, R. H. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.12.025 · Cited by 6 · see citing works

Cause, consequence or coincidence: The relationship between psychiatric disease and metabolic syndrome

Ferns, G. A. (2018) · Translational Metabolic Syndrome Research · doi:10.1016/j.tmsr.2018.04.003 · Cited by 6 · see citing works

Levels of C-reactive protein (CRP) in elderly patients with unipolar depression—Case control analysis

Wysokiński, A., Socha, K., Sołtysik, B. K., Kłoszewska, I., Sobów, T., & Kostka, T. (2016) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2016.1174298 · Cited by 5 · see citing works

Longitudinal relationships between BMI and hs-CRP among people with schizophrenia

Dyne, A. V., Wu, T., Adamowicz, D. H., Lee, E., Tu, X. M., & Eyler, L. T. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.07.050 · Cited by 5 · see citing works

In vitro cytokine synthesis in unstimulated and mitogen-stimulated peripheral blood mononuclear cells from individuals with schizophrenia

Kozłowska, E., Żelechowska, P., Wysokiński, A., Rasmus, P., Łucka, A., & Brzezińska‐Błaszczyk, E. (2019) · Journal of Investigative Medicine · doi:10.1136/jim-2018-000964 · Cited by 5 · see citing works

Protéine C-réactive et agitation chez des patients atteints de schizophrénie : suivi d’une cohorte avec groupe témoin

Kachouchi, A., Sebbani, M., Akammar, S., Berghalout, M., Adali, I., Manoudi, F., Amine, M., & Asri, F. (2020) · L Encéphale · doi:10.1016/j.encep.2019.11.007 · Cited by 5 · see citing works

Association of high-sensitivity C-reactive protein with susceptibility to Schizophrenia in Tunisian population

Ayari, F., Chaaben, A. B., Ammar, H. B., Nefzi, R., Ouni, N., Mihoub, O., Abaza, H., Aissa, A., Douik, H., Gara, S., et al. (2020) · L Encéphale · doi:10.1016/j.encep.2019.10.001 · Cited by 5 · see citing works

Self-compassion, but not compassion toward others, is associated with better physical health: A cross-sectional study

Ramsey, M., Govind, T., Lam, J. A., Palmer, B. W., Jeste, D. V., & Lee, E. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.03.017 · Cited by 5 · see citing works

Peripheral immune cell markers and cognitive function in patients with schizophrenia

Karahan, A., Saka, I. M., Aykut, D. S., Arslan, F. C., Özmen, E. S., & Karagüzel, E. Ö. (2024) · The International Journal of Psychiatry in Medicine · doi:10.1177/00912174241266059 · Cited by 4 · see citing works

A Comparison of the Relationship Between C-Reactive Protein Levels and Cognitive Functions in Patients with Schizophrenia, First-Episode Psychosis, and Healthy Controls

Demir, N., & Yildirim, O. A. (2023) · Psychiatry and Clinical Psychopharmacology · doi:10.5152/pcp.2022.22447 · Cited by 3 · see citing works

Systemic concentration of apelin, but not resistin or chemerin, is altered in patients with schizophrenia

Kozłowska, E., Brzezińska‐Błaszczyk, E., Wysokiński, A., & Żelechowska, P. (2021) · Journal of Investigative Medicine · doi:10.1136/jim-2020-001523 · Cited by 3 · see citing works

Familial Mediterranean fever association with schizophrenia: insights from big data analysis

Sharif, Κ., Watad, ‬., Bragazzi, N. L., Yavne, Y., Bridgewood, C., McGonagle, D., Comanhester, D., Cohen, A. D., & Amital, H. (2020) · Archives of Medical Science · doi:10.5114/aoms.2020.95463 · Cited by 3 · see citing works

C-Reactive Protein and Aggression in Patients with Schizophrenia

Kachouchi, A. (2019) · International Journal of Psychological and Brain Sciences · doi:10.11648/j.ijpbs.20190402.11 · Cited by 3 · see citing works

Prediction of lung cancer risk using circulating pro-surfactant protein B and high-sensitivity C-reactive protein among Egyptian workers in the rubber industry

Mourad, B. H. (2020) · Toxicology and Industrial Health · doi:10.1177/0748233720923504 · Cited by 3 · see citing works

Characterization of Anemia among Hospitalized Patients with Psychiatric Disorders

Ali, E., Zaitoun, N. A., Embaby, A., Zaitoun, N. A., & Ibrahim, D. (2022) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2022.271901 · Cited by 2 · see citing works

Schizophrenia spectrum disorders

(2023) · Advances in magnetic resonance technology and applications · doi:10.1016/b978-0-323-91771-1.00008-3 · Cited by 2 · see citing works

Evaluating the association of vitamin D3, parathyroid hormone, and C-reactive protein serum levels in patients with an acute psychotic episode: a cross-sectional study in tertiary centre in Iran

Arya, S., Kamyab, A., Sanatkar, S. A., Pourmehdiardebili, M., Ebrahimi, A., Kamyab, P., Alavi, K., Zarei, Z., & Ahmadkhaniha, H. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-05234-5 · Cited by 3 · see citing works

Improving Healthy Living in Residential Care Facilities: Feasibility, Acceptability, and Appropriateness of Implementing a Multicomponent Intervention for Diabetes Risk Reduction in Adults with Serious Mental Illnesses

Sommerfeld, D. H., Brunner, A., Glorioso, D., Lee, E., Ibarra, C., Zunshine, E., Daly, R. E., Zoumas, C., & Jeste, D. V. (2022) · Administration and Policy in Mental Health and Mental Health Services Research · doi:10.1007/s10488-022-01189-z · Cited by 2 · see citing works

High-sensitivity C-reactive protein is related to age and gender in an acute psychiatric inpatient population

Sakai, Y., Larsen, J. B., & Reitan, S. K. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e08992 · Cited by 2 · see citing works

The relationship between inflammation and cognitive function in drug-naïve schizophrenia with or without pre-metabolic syndrome

Su, Q., Wang, J., Ge, H., Li, M., Sun, X., Wang, S., Xuekelaiti, Z., Feng, Z., Xu, Y., Qiu, Y., et al. (2025) · Psychiatry Research · doi:10.1016/j.psychres.2025.116604 · Cited by 1 · see citing works

The clinical utility of the immune status questionnaire as a marker of immune function among persons with schizophrenia

Lee, J.-Y., Liu, Y.-H., Hsieh, C. L., & Lung, F. (2025) · Science Progress · doi:10.1177/00368504251405328 · Cited by 1 · see citing works

Chapter 11. Schizophrenia Spectrum and Other Psychotic Disorders

Graham, S. A., Adamowicz, D. H., Jeste, D. V., & Lee, E. (2022) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375196.ds11 · Cited by 1 · see citing works

Changes in psychopathology and peripheral inflammation in schizophrenia patients initiating treatment with second-generation antipsychotics: a post-hoc analysis

Heil, M., Edlinger, M., Biedermann, F., Schurr, T., & Hofer, A. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1644428 · Cited by 2 · see citing works

Exploring the link between inflammation and mental disorders

Effendy, E. (2018) · IOP Conference Series Earth and Environmental Science · doi:10.1088/1755-1315/125/1/012187 · Cited by 1 · see citing works

Oxidative Stress Index and Peripheral Biomarkers for Schizophrenia: A Revisited Approach.Preprint

Wasti, A. Z., Jabeen, F., Rasheed, S., Shah, N., Khan, D., Zehra, Z., Aziz, F., Riaz, A., Ahmed, S. L., Ahmed, N., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3879201/v1 · Cited by 1 · see citing works

Response to Xuerong Luo et al., Letter to the Editor

Aas, M. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.07.006

Letter to the Editor “Childhood maltreatment severity is associated with elevated C-reactive protein and body mass index in adult with schizophrenia and bipolar diagnoses”

Liu, J., He, Y., & Luo, X. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.07.007

Biological Changes in Older People with Schizophrenia

Centorino, M. B., & Schultz, S. K. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108539593.006

Correlation between C-reactive Protein Levels with Cognitive Function and Body Mass Index in Schizophrenia

Mahmuddin, P. M., Effendy, E., & Amin, M. M. (2021) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2021.6305

A literature survey on the biomarkers of cardiovascular disease

Pavithra, R., Sangeetha, T., Velayuthaprabhu, S., & Anand, A. V. (2021) · International Journal of Academic Medicine · doi:10.4103/ijam.ijam_80_20

T94. HS-CRP TO EVALUATE CHRONIC INFLAMMATION AND CARDIOVASCULAR DISEASES IN SCHIZOPHRENIA

Nefzi, R., Larnaout, A., Hanen, B. A., Khelifa, E., Aissa, A., Zouhaier, E. H., & Guémira, F. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sby016.370

Association Between High-sensitivity C-reactive Protein and Predicted Cardiovascular Risks in Schizophrenia.

Xie, Y., Wang, Y., Xu, P., & Zheng, Y. (2023) · PubMed · Cited by 1 · see citing works

C-reactive protein is elevated in schizophrenia

Dickerson, F., Stallings, C. R., Origoni, A. E., Vaughan, C., Khushalani, S., Yang, S., & Yolken, R. H. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.10.041 · Cited by 120 · see citing works

議고쁽蹂� 諛� 議고쁽�젙�룞�옣�븷 �엯�썝�솚�옄�뿉�꽌 �삁泥� �뿼利앺몴吏��옄�� �젙�떊蹂묒쟻利앹긽怨쇱쓽 愿��젴�꽦

諛뺤쭊�쁺 (2012) · YUHSpace (Yonsei University Medical Library)

SU6. Association of High Risk of Cardiovascular Disease With Increased Serum hsCRP Levels Progressively in Patients With Schizophrenia

Yao, J., Reddy, R. D., Dougherty, G., Magan, S., Gurklis, J. A., Sonel, A. F., Sonel, E., Kisslinger, B., Chengappa, K. N. R., & Keshavan, M. S. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx024.005